Click image to enlarge
U-PLEX Combos offer popular panels of biomarkers that have been grouped together for convenient ordering. They have been tested for multiplex compatibility and are fulfilled as a kit. The U-PLEX Viral Combo 1 (human) combines 20 analytes (Table 1) that have been associated with immune response to viral infection. The assays can be used for quantitative measurements of the sample type(s) listed in the "Specifications" tab below, and offer detection limits (LLODs) in the sub-to low pg/mL range.
Analyte | LLOD - ULOD | units |
G-CSF | 1.6 - 20,400 | pg/mL |
GM-CSF | 0.12 - 9,440 | pg/mL |
IFN-α2a | 4.0 - 42,400 | pg/mL |
IFN-β | 3.1 - 100,000 | pg/mL |
IFN-γ | 1.7 - 17,000 | pg/mL |
IL-1RA | 1.7 - 5,000 | pg/mL |
IL-1β | 0.15 - 3,820 | pg/mL |
IL-4 | 0.08 - 2,060 | pg/mL |
IL-5 | 0.24 - 4,040 | pg/mL |
IL-6 | 0.33 - 1,980 | pg/mL |
Analyte | LLOD - ULOD | units |
IL-7 | 1.5 - 7,040 | pg/mL |
IL-8 | 0.15 - 2,210 | pg/mL |
IL-9 | 0.14 - 1,500 | pg/mL |
IL-10 | 0.14 - 3,720 | pg/mL |
IL-12p70 | 0.69 - 5,320 | pg/mL |
IP-10 | 0.49 - 6,000 | pg/mL |
MCP-1 | 0.74 - 6,560 | pg/mL |
MIP-1α | 7.7 - 4,200 | pg/mL |
TNF-α | 0.51 - 3,650 | pg/mL |
VEGF-A | 2.0 - 4,920 | pg/mL |
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
Application(s)
|
|
Immunology/Inflammation
|
|
Analyte(s)
|
|
G-CSF, GM-CSF, IFN-α2a, IFN-β, IFN-γ, IL-1β, IL-1RA, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12p70, IP-10, MCP-1, MIP-1α, TNF-α, VEGF-A
|
|
Species
|
|
Human
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120
|
|
U-PLEX Group Compatibility
|
|
Biomarker Group 1
|
|
Plate Type
|
|
96-well
|
|
Sample Type
|
|
Serum, Plasma, Cell Culture Supernatant
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3002.15.0100
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Human Viral Combo 1, Box 1 of 2
|
Multi-Component
|
1 each (1 plate size)
|
|
Human Viral Combo 1, Box 2 of 2
|
Multi-Component
|
1 each (1 plate size)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Human Viral Combo 1, Box 1 of 2
|
Multi-Component
|
1 each (5 plate size)
|
|
Human Viral Combo 1, Box 2 of 2
|
Multi-Component
|
1 each (5 plate size)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Human Viral Combo 1, Box 2 of 2
|
Multi-Component
|
1 each (25 plate size)
|
|
Human Viral Combo 1, Box 2 of 2
|
Multi-Component
|
1 each (25 plate size)
|
|
Product Inserts
|
|
|
Datasheets
|
|
View More
|
Product Highlights
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke
|
|
|
|
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms
|
|
|
|
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
|
|
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
IL-6 as a Mediator of the Association Between Traditional Risk Factors and Future Myocardial Infarction: A Nested Case-Control Study
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters